betnovate 0.1 % crema tópica
glaxosmithkline brasil ltda. de brasil - betametasona valerato (micronizada) - betametasona valerato (micronizada)....0.122 %
dermovate al 0.05 % crema
glaxosmithkline brasil ltda - clobetasol propionato - clobetasol propionato ....0,05g
cutivate 0,05 % crema topica.
glaxosmithkline brasil ltda - propionato de fluticasona (micronizado) - propionato de fluticasona (micronizado)....0.05 g
zovirax al 5% crema
glaxosmithkline brasil ltda. - aciclovir - aciclovir....5.00 g.
emulsion de scott sabor a naranja
glaxosmithkline brasil ltda. - vitamina a palmitato - vitamina a palmitato....0.0652mg / vitamina d3....0.0045mg / aceite de hÍgado de bacalao equivalente a vit. a....10.0000mg
emulsion scott sabor a cereza
glaxosmithkline brasil ltda. - vitamina a palmitato - vitamina a palmitato....0.0652 mg / vitamina d3....0.0045 mg / aceite de hÍgado de bacalao equivalente a vit. a....10.0000 mg
emulsión de scott sabor a frutas tropicales
glaxosmithkline brasil ltda. - vitamina a palmitato - vitamina a palmitato....0.0652mg/ml / vitamina d3....0.0045mg/ml / aceite de hÍgado de bacalao equivalente a vit. a....10.0000 mg
dermovate 0.05 % ungüento tópico
glaxosmithkline brasil ltda. - propionato de clobetasol - propionato de clobetasol....0.05 g
bactroban 2 % ungüento topico
glaxosmithkline brasil ltda. - mupirocina - mupirocina....20.00 mg
prepandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals
glaxosmithkline biologicals s.a. - split influenza virus, inactivated, containing antigen: a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14) - influenza, human; immunization; disease outbreaks - vaccines - active immunisation against h5n1 subtype of influenza a virus.this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of vaccine prepared from a/vietnam/1194/2004 nibrg-14 (h5n1) (see section 5.1).prepandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals 3.75 µg should be used in accordance with official guidance.